This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Deals

Consistently ranked as one of the UK’s most active dealmakers

eXmoor Pharma

Advised eXmoor Pharma on their $35 million Series A investment from US based Kineticos and existing investor MVM Partners.

Fundraising May 2023

eXmoor Pharma

Advised eXmoor Pharma on £12m investment from MVN Partners.

Fundraising June 2017